Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.45
(0.0%)
CNY 7.45
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 50.82 Million CNY | 23.34% |
| 2022 | 41.21 Million CNY | 181.72% |
| 2021 | 14.62 Million CNY | -96.87% |
| 2020 | 466.91 Million CNY | 9.17% |
| 2019 | 427.71 Million CNY | 755.43% |
| 2018 | 50 Million CNY | -72.22% |
| 2017 | 179.95 Million CNY | -14.65% |
| 2016 | 210.84 Million CNY | 144.02% |
| 2015 | 86.4 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 20 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 60.91 Million CNY | 5.59% |
| 2024 Q1 | 70.31 Million CNY | 38.34% |
| 2024 Q2 | 61.54 Million CNY | -12.47% |
| 2023 Q3 | 34.83 Million CNY | 37.48% |
| 2023 Q2 | 25.33 Million CNY | -34.44% |
| 2023 FY | 50.82 Million CNY | 23.34% |
| 2023 Q4 | 50.82 Million CNY | 45.92% |
| 2023 Q1 | 38.64 Million CNY | -6.22% |
| 2022 Q4 | 41.21 Million CNY | -16.85% |
| 2022 Q3 | 49.56 Million CNY | 108.82% |
| 2022 Q1 | 24.18 Million CNY | 65.34% |
| 2022 FY | 41.21 Million CNY | 181.72% |
| 2022 Q2 | 23.73 Million CNY | -1.87% |
| 2021 Q2 | 453.54 Million CNY | -21.12% |
| 2021 Q4 | 14.62 Million CNY | 305.88% |
| 2021 FY | 14.62 Million CNY | -96.87% |
| 2021 Q1 | 574.96 Million CNY | 23.14% |
| 2021 Q3 | 3.6 Million CNY | -99.21% |
| 2020 Q1 | 567.71 Million CNY | 32.73% |
| 2020 Q2 | 444.07 Million CNY | -21.78% |
| 2020 Q4 | 466.91 Million CNY | -15.58% |
| 2020 FY | 466.91 Million CNY | 9.17% |
| 2020 Q3 | 553.08 Million CNY | 24.55% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 FY | 427.71 Million CNY | 755.43% |
| 2019 Q4 | 427.71 Million CNY | 0.0% |
| 2019 Q1 | 50 Million CNY | 0.0% |
| 2019 Q2 | 50 Million CNY | 0.0% |
| 2018 Q1 | 90 Million CNY | -49.99% |
| 2018 FY | 50 Million CNY | -72.22% |
| 2018 Q4 | 50 Million CNY | 0.0% |
| 2018 Q3 | 50 Million CNY | -62.1% |
| 2018 Q2 | 131.93 Million CNY | 46.59% |
| 2017 Q4 | 179.95 Million CNY | -5.68% |
| 2017 FY | 179.95 Million CNY | -14.65% |
| 2017 Q1 | 207.31 Million CNY | -1.67% |
| 2017 Q2 | 222.3 Million CNY | 7.23% |
| 2017 Q3 | 190.79 Million CNY | -14.17% |
| 2016 Q4 | 210.84 Million CNY | 6.12% |
| 2016 Q2 | 170.77 Million CNY | 37.0% |
| 2016 Q1 | 124.65 Million CNY | 44.27% |
| 2016 Q3 | 198.68 Million CNY | 16.34% |
| 2016 FY | 210.84 Million CNY | 144.02% |
| 2015 Q3 | 45.58 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 86.4 Million CNY | 0.0% |
| 2015 Q4 | 86.4 Million CNY | 89.55% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2012 FY | 20 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |